Adverum Biotechnologies (ADVM) Misses Q3 EPS by 130c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($1.30). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• U.S. and Denmark close in on a Greenland deal - Reuters
• Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
• Teva shares Phase 3 data on once-monthly schizophrenia injection